Financhill
Sell
6

MRNA Quote, Financials, Valuation and Earnings

Last price:
$39.59
Seasonality move :
9.23%
Day range:
$39.12 - $40.83
52-week range:
$35.80 - $170.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.01x
P/B ratio:
1.27x
Volume:
35M
Avg. volume:
10.1M
1-year change:
-54.3%
Market cap:
$15.2B
Revenue:
$6.8B
EPS (TTM):
-$5.82

Earnings Data

Next earnings date for MRNA
Feb 21
2025
Most recent earnings per share
$0.03
Beat by $1.97
(Nov 7/2024)
Consensus Estimate
-$1.94
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MRNA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/21/2025 Q4 $1.1B -- -- -$2.76 --
11/07/2024 Q3 $1.2B $1.9B $0.03 -$1.94 $1.97
08/01/2024 Q2 $134.9M $221M -$3.33 -$3.36 $0.03
05/02/2024 Q1 $125.3M $167M -$3.07 -$3.55 $0.48
02/22/2024 Q4 $2.5B $2.8B $0.55 -$0.99 $1.54
11/02/2023 Q3 -- -- -$9.53 -$2.05 -$7.48
06/30/2023 Q2 -- -- -$3.62 -$4.12 $0.50
03/31/2023 Q1 -- -- $0.19 -$1.73 $1.92
12/31/2022 Q4 -- -- $3.61 $4.60 -$0.99
09/30/2022 Q3 -- -- $2.53 $3.11 -$0.58
06/30/2022 Q2 -- -- $5.24 $4.49 $0.75
03/31/2022 Q1 -- -- $8.58 -- --
12/31/2021 Q4 -- -- $11.29 -- --
09/30/2021 Q3 -- -- $7.70 -- --
06/30/2021 Q2 -- -- $6.46 -- --
03/31/2021 Q1 -- -- $2.84 -- --
12/31/2020 Q4 -- -- -$0.69 -- --
09/30/2020 Q3 -- -- -$0.59 -- --
06/30/2020 Q2 -- -- -$0.31 -- --
03/31/2020 Q1 -- -- -$0.35 -- --
12/31/2019 Q4 -- -- -$0.37 -- --
09/30/2019 Q3 -- -- -$0.37 -- --
06/30/2019 Q2 -- -- -$0.41 -- --
03/31/2019 Q1 -- -- -$0.40 -- --
12/31/2018 Q4 -- -- -$0.43 -- --
09/30/2018 Q3 -- -- -$0.27 -- --
06/30/2018 Q2 -- -- -$0.24 -- --
03/31/2018 Q1 -- -- -$0.19 -- --
12/31/2017 Q4 -- -- -$0.10 -- --

Moderna Earnings Questions

  • How Much did Moderna Generate in Revenue Last Quarter?

    Moderna reported $1.9B worth of top line sales in its most recent quarter.

  • Did Moderna Beat Earnings Last Quarter?

    Moderna announced earnings per share of $0.03 which represents a beat of analyst forecast a -$1.94 per share.

  • Is Moderna Profitable?

    Moderna reported $1.3B that represents $3.36 per share over the last quarter.

  • What is the Analyst Consensus for Moderna EPS Next Year?

    Moderna's earnings are forecast to decrease from -$12.33 per share to -$13.51 per share next year representing a decrease of -24.76%.

  • When is Moderna's Earnings Date?

    Moderna's next earnings date is February 21, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 2.59% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.68% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock